Current Management of Patients with Severe Aortic Regurgitation
| Autor: | Charles Nadeau-Routhier, Jonathan Beaudoin, Ons Marsit |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Aortic valve
medicine.medical_specialty Percutaneous business.industry medicine.medical_treatment Incidence (epidemiology) valvular heart disease Regurgitation (circulation) 030204 cardiovascular system & hematology medicine.disease Surgery 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure Valve replacement Aortic valve replacement Internal medicine medicine Cardiology 030212 general & internal medicine Cardiology and Cardiovascular Medicine business Adverse effect |
| Zdroj: | Current treatment options in cardiovascular medicine. 19(2) |
| ISSN: | 1092-8464 |
| Popis: | Chronic aortic regurgitation can result from various congenital and acquired anomalies and can be associated with proximal aortic disease. As the number of aortic valve procedures is growing, the incidence of post-procedural regurgitation also increases with associated morbidity. Typical evolution is characterized by a clinically silent phase of variable duration followed by a rather rapid decline with high incidence of adverse events. A challenge remains to find the optimal timing for an intervention: Patients are exposed to unnecessary surgical risks if treated prematurely, but peri- and post-operative prognosis is worse when the intervention is performed too late. Clinical evaluation and serial imaging tests can optimize the timing for intervention. Clinical follow-up should try to elucidate associated symptoms, with quantitative measurement of functional capacity as needed. Serial imaging examinations are required to identify sub-clinical left ventricular dysfunction or severe dilatation that should prompt a surgery. At least in selected cases, newer imaging modalities (MRI, 3D echocardiography) and/or biomarkers can help for the management of these patients, and more research is needed to determine if their systematic use can be beneficial. Medical treatment with vasodilators and anti-remodeling drugs can be helpful in some patients but should not replace or delay aortic valve surgery when indicated. Most patients will eventually be treated with surgical aortic valve replacement. Although possible in selected cases, transcatheter aortic valve replacement is not commonly used for patients with pure aortic regurgitation. For patients with prior aortic valve replacement and aortic regurgitation (paravalvular or intravalvular), emerging percutaneous approaches can be considered when available, especially for those at high surgical risk. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink